Rituximab and Vascular Diseases
Links shared publicly online about this topic
Rituximab shows tolerability, potential efficacy in treating thyroid eye disease
osnsupersite.com — “Rituximab-mediated B-lymphocyte depletion yielded promising early results in the treatment of thyroid eye disease, a study found. "The v” View full resource at osnsupersite.com
Most Recently Shared on September 29, 2010 at 5:20 am By:
Rituximab shows tolerability, potential efficacy in treating #thyroid #eye #disease: http://ht.ly/2LgwS
Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial : The Lancet
thelancet.com — “Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial. By - Prof Gilles...” View full resource at thelancet.com
Most Recently Shared on December 21, 2010 at 5:08 pm By:
Testing the hypothesis that helminth infections during pregnancy attenuate responses of infants to vaccination http://bit.ly/g1oP6f
Mabthera(R) (Rituximab) Approved In UK For Relapsed And Difficult-To-Treat Patients With Most Common Leukaemia
medicalnewstoday.com — “Mabthera® (rituximab) is now available in the uk for relapsed and difficult-to-treat (refractory) patients with chronic lymphocytic leukaemia (cll),1 the most common form of leukaemia.2,3,4 ri” View full resource at medicalnewstoday.com
Most Recently Shared on October 1, 2009 at 10:36 am By:
Mabthera(R) (Rituximab) Approved In UK For Relapsed And Difficult-To-Treat Patients With Most Common Leukaemia:.. http://bit.ly/BgCGu
TRACTISS to Study Rituximab Effects in Sjgren's Syndrome : Internal Medicine News
internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre” View full resource at internalmedicinenews.com
Most Recently Shared on May 16, 2011 at 5:55 pm By:
Bob Finn - Medical News Net Health News
For Sjogren's syndrome, trial of rituximab vs. placebo enrolling patients soon in UK. Sara Freeman reports. http://bit.ly/jzDNb4
Medical News: Neutropenia an Issue in RA Patients on Rituximab - in Rheumatology, General Rheumatology from MedPage Today
medpagetoday.com — “Late-onset neutropenia is a clinically important adverse event among patients with rheumatic disease treated with the monoclonal antibody rituximab (Rituxan) because serious infections can occur, a re” View full resource at medpagetoday.com
Most Recently Shared on August 4, 2011 at 7:15 pm By:
Neutropenia an Issue in RA Patients on Rituximab (CME/CE) http://bit.ly/qZxk9l
Rituximab Deemed Useful for Certain Lupus Subgroups : Skin & Allergy News
skinandallergynews.com — “Skin & Allergy News Digital Network is the online destination and multimedia properties of Skin & Allergy News, the independent news publication for the dermatology community. Our breaking news covers all areas of medical dermatology, dermatologic surgery, and aesthetic dermatology. We also provide the news by specialty interest: acne and rosacea, atopic dermatitis and eczema, cutaneous oncology, hair and nails, infectious diseases, pediatric dermatology, psoriasis and rheumatologic disorders, s” View full resource at skinandallergynews.com
Most Recently Shared on June 10, 2011 at 7:21 pm By:
Skin & Allergy News Health News
Rituximab Deemed Useful for Certain Lupus Subgroups http://tinyurl.com/6ena54w
Rituxan (Rituximab) for Rheumatoid Arthritis and Non-Hodgkins Lymphoma
rituxan.com — “Rituxan (Rituximab) is a unique therapy that works by selectively depleting CD20+ B-cells. B-cells, and their role in cancer and autoimmune diseases, have been an area of intensive research by scientists around the world, and at Genentech and Biogen Idec. Rituxan affects your immune system by selectively targeting CD20+ B-cells shown to play an important role in non-Hodgkin's lymphoma and rheumatoid arthritis.” View full resource at rituxan.com
Most Recently Shared on November 11, 2009 at 3:21 am By:
Rituxan generally indicated for RA when when the use of 1+TNF antagonist drug response is inadequate http://www.rituxan.com/
Indolent Lymphoma: Can Rituximab Resolve the Watch-and-Wait Debate? -- Ross 102 (4): 220 -- JNCI Journal of the National Cancer Institute
jnci.oxfordjournals.org — “Indolent Lymphoma: Can Rituximab Resolve the Watch-and-Wait Debate? -- Ross 102 (4): 220 -- JNCI Journal of the National Cancer Institute” View full resource at jnci.oxfordjournals.org
Most Recently Shared on February 12, 2010 at 9:18 pm By:
J Nat'l Cancer Inst Medical Journal and Oncology
JNCI news story: Indolent lymphoma: to treat or to watch and wait? Will rituximab resolve that debate? http://bit.ly/9UgIge
Role of Intrathecal Rituximab and Trastuzumab in the Management of Leptomeningeal Carcinomatosis (October) -- Perissinotti and Reeves, 10.1345/aph.1P197 -- The Annals of Pharmacotherapy
theannals.com — “Role of Intrathecal Rituximab and Trastuzumab in the Management of Leptomeningeal Carcinomatosis (October) -- Perissinotti and Reeves, 10.1345/aph.1P197 -- The Annals of Pharmacotherapy” View full resource at theannals.com
Most Recently Shared on September 1, 2010 at 2:16 am By:
Role of Intrathecal Rituximab and Trastuzumab in the Management of Leptomeningeal Carcinomatosis (October): ... http://bit.ly/cKB1wf
Rituximab in the Treatment of Bullous Systemic Lup... [J Clin Rheumatol. 2011] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on April 3, 2011 at 3:22 pm By:
Lupus Doctor Doctor, Internist, Rheumatologist, and Physician
Another example of off label use of rituximab helping lupus:refractory with atypical manifestion of skin diseases http://1.usa.gov/fCWv1P
Up-Front Rituximab Prolongs Progression-Free Survival in Follicular Lymphoma : Hospitalist News
ehospitalistnews.com — “Hospitalist News Digital Network is the online destination and multimedia properties of Hospitalist News, the independent news publication. Our breaking news covers all areas of hospital-based practice including cardiovascular disease; critical care medicine; diabetes, endocrinology and metabolism; gastroenterology; infectious diseases; hematology; imaging; nephrology; neurology; palliative care and hospice; perioperative medicine; pulmonary disease; pediatrics; practice trends; and trauma. We a” View full resource at ehospitalistnews.com
Most Recently Shared on December 9, 2010 at 12:49 am By:
Bob Finn - Medical News Net Health News
Start rituximab early in patients with follicular lymphoma. Neil Osterweil reports. http://bit.ly/gNTLGE
Rituximab Maintenance Called "New Standard" for Mantle Cell Lymphoma : Internal Medicine News
internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre” View full resource at internalmedicinenews.com
Most Recently Shared on June 20, 2011 at 4:07 pm By:
Bob Finn - Medical News Net Health News
Rituximab Maintenance Called "New Standard" for Mantle Cell Lymphoma, Sara Freeman reports: http://bit.ly/kcwjUF
Neutropenia an Issue in RA Patients on Rituximab (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- Late-onset neutropenia is a clinically important adverse event among patients with rheumatic disease treated with the monoclonal antibody rituximab (Rituxan) because serious infections can occur, a retrospective analysis suggested.” View full resource at qualitypointtech.net
Most Recently Shared on August 4, 2011 at 7:00 pm By:
Neutropenia an Issue in RA Patients on Rituximab (CME/CE): (MedPage Today) -- Late-onset neutropenia is a clinical... http://bit.ly/nl6NkZ
Rheumatology Article | Retreatment with rituximab based on a treatment-to-target approach provides better disease control than treatment as needed in patients with rheumatoid arthritis: A retrospective pooled analysis
mdlinx.com — “Retreatment with rituximab based on a treatment-to-target approach provides better disease control than treatment as needed in patients with rheumatoid arthritis: A retrospective pooled analysis” View full resource at mdlinx.com
Most Recently Shared on October 10, 2011 at 8:49 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Retreatment with rituximab based on a treatment-to-target approach provides better disease control... http://t.co/Lw9o6g27 #Rheumatology
Statins inhibit the antirheumatic effects of rituximab in rheumatoid arthritis: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry -- Arts et al. -- Annals of the Rheumatic Diseases
ard.bmj.com — “Arts, E E A; Jansen, T L; Broeder, A Den; Vonkeman, H E; Dutmer, E; Van de Laar, M A F J; Van Riel, P L C M; Fransen, J” View full resource at ard.bmj.com
Most Recently Shared on October 28, 2010 at 2:29 pm By:
Norman Marcus, M.D. Doctor, Pain Medicine Physician, and Physician
Rheumatoid Arthritis? Statins inhibit the effect of retuximab. Important new information. http://cot.ag/dzrOvf
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
The OSN SuperSite
The Online home of Ocular Surgery News streamlined for the Web-savvy ophthalmic professional.
-
The Lancet
Welcome to the Lancet.com on Twitter. Keep in touch with The Lancet, the world's leading general medical journal.
-
MNT Cancer News
The latest cancer news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
